{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:04:53Z","timestamp":1785380693893,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.neulet.2012.02.037","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T20:02:27Z","timestamp":1329940947000},"page":"193-197","source":"Crossref","is-referenced-by-count":50,"title":["Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway"],"prefix":"10.1016","volume":"513","author":[{"given":"Dan B.","family":"Renner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"William H.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah R.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2012.02.037_bib0005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.exger.2010.08.026","article-title":"Intranasal insulin as a therapeutic option in the treatment of cognitive impairments","volume":"46","author":"Benedict","year":"2011","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neulet.2012.02.037_bib0010","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neulet.2012.02.037_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2011.92","article-title":"Selective siRNA-mediated suppression of 5-HT(1A) autoreceptors evokes strong anti-depressant-like effects","author":"Bortolozzi","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2012.02.037_bib0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-1998-1102","article-title":"Delivery of nerve growth factor to the brain via the olfactory pathway","volume":"1","author":"Chen","year":"1998","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2012.02.037_bib0025","unstructured":"W.H.F.I. Christoph Reinjard, Delivery of Polynucleotide Agents to the Central Nervous System, US 2009\/0264506 A1 (2009)."},{"key":"10.1016\/j.neulet.2012.02.037_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2012.02.037_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/rej.2010.1130","article-title":"Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease","volume":"14","author":"Danielyan","year":"2011","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.neulet.2012.02.037_bib0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejcb.2009.02.001","article-title":"Intranasal delivery of cells to the brain","volume":"88","author":"Danielyan","year":"2009","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.neulet.2012.02.037_bib0045","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/jps.21604","article-title":"Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system","volume":"98","author":"Dhuria","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.neulet.2012.02.037_bib0050","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.neulet.2012.02.037_bib0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev.bioeng.8.061505.095848","article-title":"Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs","volume":"8","author":"Dykxhoorn","year":"2006","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.neulet.2012.02.037_bib0060","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/B:NEUR.0000010089.37032.48","article-title":"Ensheathment of the olfactory nerves in the adult rat","volume":"32","author":"Field","year":"2003","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.neulet.2012.02.037_bib0065","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1093\/brain\/awn288","article-title":"Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy","volume":"131","author":"Francis","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2012.02.037_bib0070","unstructured":"W.H. Frey 2nd, Method of Administering Neurologic Agents to the Brain 5,624,898 (1997)."},{"issue":"Suppl. 3","key":"10.1016\/j.neulet.2012.02.037_bib0075","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2202-9-S3-S5","article-title":"Intranasal delivery bypasses the blood\u2013brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9","author":"Hanson","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neulet.2012.02.037_bib0080","first-page":"81","article-title":"Intranasal administration of hypocretin 1 (Orexin A) bypasses the blood\u2013brain barrier & targets the brain: a new strategy for the treatment of narcolepsy","volume":"4","author":"Hanson","year":"2004","journal-title":"Drug Deliv. Technol."},{"key":"10.1016\/j.neulet.2012.02.037_bib0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1215\/15228517-2007-052","article-title":"New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163","volume":"10","author":"Hashizume","year":"2008","journal-title":"Neurol. Oncol."},{"key":"10.1016\/j.neulet.2012.02.037_bib0090","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/1061186021000001823","article-title":"Visualization of in vivo olfactory uptake and transfer using fluorescein dextran","volume":"10","author":"Jansson","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.neulet.2012.02.037_bib0095","first-page":"285","article-title":"Gener knockdown in the olfactory bulb, amygdala, and hypothalamus by intranasal siRNA administration","volume":"42","author":"Kim","year":"2009","journal-title":"Kor. J. Anat."},{"key":"10.1016\/j.neulet.2012.02.037_bib0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/glia.20241","article-title":"Olfactory ensheathing cells and olfactory nerve fibroblasts maintain continuous open channels for regrowth of olfactory nerve fibres","volume":"52","author":"Li","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.neulet.2012.02.037_bib0105","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1039\/b701169e","article-title":"Targeting neurological disease with RNAi","volume":"3","author":"Lingor","year":"2007","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.neulet.2012.02.037_bib0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.brainresbull.2007.06.021","article-title":"Intranasally delivered TGF-beta1 enters brain and regulates gene expressions of its receptors in rats","volume":"74","author":"Ma","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neulet.2012.02.037_bib0115","first-page":"158","article-title":"RNAi therapeutics: an update on delivery","volume":"10","author":"Nguyen","year":"2008","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.neulet.2012.02.037_bib0120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1124\/jpet.107.132381","article-title":"Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins","volume":"325","author":"Nonaka","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2012.02.037_bib0125","first-page":"97","article-title":"[Olfactory disorders in Alzheimer's disease and in Parkinson's disease. Review of the literature]","volume":"151","author":"Nores","year":"2000","journal-title":"Ann. Med. Intern. (Paris)"},{"key":"10.1016\/j.neulet.2012.02.037_bib0130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2012.02.037_bib0135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-2008-13309","article-title":"Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults","volume":"13","author":"Reger","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2012.02.037_bib0140","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2012.02.037_bib0145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2004.02.011","article-title":"Intranasal administration of interferon beta bypasses the blood\u2013brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis","volume":"151","author":"Ross","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neulet.2012.02.037_bib0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2741\/3245","article-title":"Potential application of RNAi for understanding and therapy of neurodegenerative diseases","volume":"14","author":"Schwartz","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.neulet.2012.02.037_bib0155","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1111\/j.1742-4658.2010.07904.x","article-title":"Efficient and targeted delivery of siRNA in vivo","volume":"277","author":"Shim","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.neulet.2012.02.037_bib0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2012.02.037_bib0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev."},{"key":"10.1016\/j.neulet.2012.02.037_bib0170","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1517\/17425247.5.10.1159","article-title":"From nose to brain: understanding transport capacity and transport rate of drugs","volume":"5","author":"Wu","year":"2008","journal-title":"Expert Opin. Drug Deliv."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394012002364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394012002364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T23:26:53Z","timestamp":1543188413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394012002364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0304394012002364"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2012.02.037","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}